| 发明名称 |
NITROGENATED HETEROCYCLIC COMPOUND |
| 摘要 |
The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification , or a salt thereof |
| 申请公布号 |
TN2014000416(A1) |
申请公布日期 |
2016.03.30 |
| 申请号 |
TN20140000416 |
申请日期 |
2014.10.02 |
| 申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
TANIGUCHI TAKAHIKO;MIKAMI SATOSHI;NAKAMURA SHINJI;ASHIZAWA TOMOKO;SASAKI SHIGEKAZU;NOMURA IZUMI;KAWASAKI MASANORI |
| 分类号 |
A61K31/4985;A61P25/18;A61P43/00;C07D471/04 |
主分类号 |
A61K31/4985 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
